Glycan structure of Gc Protein-derived Macrophage Activating Factor as revealed by mass spectrometry

Chad Borges, Douglas S. Rehder

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Disagreement exists regarding the O-glycan structure attached to human vitamin D binding protein (DBP). Previously reported evidence indicated that the O-glycan of the Gc1S allele product is the linear core 1 NeuNAc-Gal-GalNAc-Thr trisaccharide. Here, glycan structural evidence is provided from glycan linkage analysis and over 30 serial glycosidase-digestion experiments which were followed by analysis of the intact protein by electrospray ionization mass spectrometry (ESI-MS). Results demonstrate that the O-glycan from the Gc1F protein is the same linear trisaccharide found on the Gc1S protein and that the hexose residue is galactose. In addition, the putative anti-cancer derivative of DBP known as Gc Protein-derived Macrophage Activating Factor (GcMAF, which is formed by the combined action of β-galactosidase and neuraminidase upon DBP) was analyzed intact by ESI-MS, revealing that the activating E. coli β-galactosidase cleaves nothing from the protein—leaving the glycan structure of active GcMAF as a Gal-GalNAc-Thr disaccharide, regardless of the order in which β-galactosidase and neuraminidase are applied. Moreover, glycosidase digestion results show that α-N-Acetylgalactosamindase (nagalase) lacks endoglycosidic function and only cleaves the DBP O-glycan once it has been trimmed down to a GalNAc-Thr monosaccharide—precluding the possibility of this enzyme removing the O-glycan trisaccharide from cancer-patient DBP in vivo.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalArchives of Biochemistry and Biophysics
Volume606
DOIs
StatePublished - Sep 15 2016

Fingerprint

Macrophage-Activating Factors
Mass spectrometry
Polysaccharides
Mass Spectrometry
Galactosidases
Trisaccharides
Carrier Proteins
Proteins
Electrospray ionization
Electrospray Ionization Mass Spectrometry
Glycoside Hydrolases
Neuraminidase
Digestion
Vitamin D-Binding Protein
Hexoses
Disaccharides
Galactose
Escherichia coli
Neoplasms
Alleles

Keywords

  • Disaccharide
  • ESI-MS
  • GcMAF
  • Linear trisaccharide
  • Linkage analysis
  • Vitamin D binding protein

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Medicine(all)
  • Molecular Biology

Cite this

Glycan structure of Gc Protein-derived Macrophage Activating Factor as revealed by mass spectrometry. / Borges, Chad; Rehder, Douglas S.

In: Archives of Biochemistry and Biophysics, Vol. 606, 15.09.2016, p. 1-13.

Research output: Contribution to journalArticle

@article{f69bd2ce38fa400ab7af7be817cb32b2,
title = "Glycan structure of Gc Protein-derived Macrophage Activating Factor as revealed by mass spectrometry",
abstract = "Disagreement exists regarding the O-glycan structure attached to human vitamin D binding protein (DBP). Previously reported evidence indicated that the O-glycan of the Gc1S allele product is the linear core 1 NeuNAc-Gal-GalNAc-Thr trisaccharide. Here, glycan structural evidence is provided from glycan linkage analysis and over 30 serial glycosidase-digestion experiments which were followed by analysis of the intact protein by electrospray ionization mass spectrometry (ESI-MS). Results demonstrate that the O-glycan from the Gc1F protein is the same linear trisaccharide found on the Gc1S protein and that the hexose residue is galactose. In addition, the putative anti-cancer derivative of DBP known as Gc Protein-derived Macrophage Activating Factor (GcMAF, which is formed by the combined action of β-galactosidase and neuraminidase upon DBP) was analyzed intact by ESI-MS, revealing that the activating E. coli β-galactosidase cleaves nothing from the protein—leaving the glycan structure of active GcMAF as a Gal-GalNAc-Thr disaccharide, regardless of the order in which β-galactosidase and neuraminidase are applied. Moreover, glycosidase digestion results show that α-N-Acetylgalactosamindase (nagalase) lacks endoglycosidic function and only cleaves the DBP O-glycan once it has been trimmed down to a GalNAc-Thr monosaccharide—precluding the possibility of this enzyme removing the O-glycan trisaccharide from cancer-patient DBP in vivo.",
keywords = "Disaccharide, ESI-MS, GcMAF, Linear trisaccharide, Linkage analysis, Vitamin D binding protein",
author = "Chad Borges and Rehder, {Douglas S.}",
year = "2016",
month = "9",
day = "15",
doi = "10.1016/j.abb.2016.08.006",
language = "English (US)",
volume = "606",
pages = "1--13",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Glycan structure of Gc Protein-derived Macrophage Activating Factor as revealed by mass spectrometry

AU - Borges, Chad

AU - Rehder, Douglas S.

PY - 2016/9/15

Y1 - 2016/9/15

N2 - Disagreement exists regarding the O-glycan structure attached to human vitamin D binding protein (DBP). Previously reported evidence indicated that the O-glycan of the Gc1S allele product is the linear core 1 NeuNAc-Gal-GalNAc-Thr trisaccharide. Here, glycan structural evidence is provided from glycan linkage analysis and over 30 serial glycosidase-digestion experiments which were followed by analysis of the intact protein by electrospray ionization mass spectrometry (ESI-MS). Results demonstrate that the O-glycan from the Gc1F protein is the same linear trisaccharide found on the Gc1S protein and that the hexose residue is galactose. In addition, the putative anti-cancer derivative of DBP known as Gc Protein-derived Macrophage Activating Factor (GcMAF, which is formed by the combined action of β-galactosidase and neuraminidase upon DBP) was analyzed intact by ESI-MS, revealing that the activating E. coli β-galactosidase cleaves nothing from the protein—leaving the glycan structure of active GcMAF as a Gal-GalNAc-Thr disaccharide, regardless of the order in which β-galactosidase and neuraminidase are applied. Moreover, glycosidase digestion results show that α-N-Acetylgalactosamindase (nagalase) lacks endoglycosidic function and only cleaves the DBP O-glycan once it has been trimmed down to a GalNAc-Thr monosaccharide—precluding the possibility of this enzyme removing the O-glycan trisaccharide from cancer-patient DBP in vivo.

AB - Disagreement exists regarding the O-glycan structure attached to human vitamin D binding protein (DBP). Previously reported evidence indicated that the O-glycan of the Gc1S allele product is the linear core 1 NeuNAc-Gal-GalNAc-Thr trisaccharide. Here, glycan structural evidence is provided from glycan linkage analysis and over 30 serial glycosidase-digestion experiments which were followed by analysis of the intact protein by electrospray ionization mass spectrometry (ESI-MS). Results demonstrate that the O-glycan from the Gc1F protein is the same linear trisaccharide found on the Gc1S protein and that the hexose residue is galactose. In addition, the putative anti-cancer derivative of DBP known as Gc Protein-derived Macrophage Activating Factor (GcMAF, which is formed by the combined action of β-galactosidase and neuraminidase upon DBP) was analyzed intact by ESI-MS, revealing that the activating E. coli β-galactosidase cleaves nothing from the protein—leaving the glycan structure of active GcMAF as a Gal-GalNAc-Thr disaccharide, regardless of the order in which β-galactosidase and neuraminidase are applied. Moreover, glycosidase digestion results show that α-N-Acetylgalactosamindase (nagalase) lacks endoglycosidic function and only cleaves the DBP O-glycan once it has been trimmed down to a GalNAc-Thr monosaccharide—precluding the possibility of this enzyme removing the O-glycan trisaccharide from cancer-patient DBP in vivo.

KW - Disaccharide

KW - ESI-MS

KW - GcMAF

KW - Linear trisaccharide

KW - Linkage analysis

KW - Vitamin D binding protein

UR - http://www.scopus.com/inward/record.url?scp=84981165124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981165124&partnerID=8YFLogxK

U2 - 10.1016/j.abb.2016.08.006

DO - 10.1016/j.abb.2016.08.006

M3 - Article

C2 - 27503803

AN - SCOPUS:84981165124

VL - 606

SP - 1

EP - 13

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

ER -